Martin Gertsch is an experienced Board Member and Financial Advisor in the life sciences industry. Up to 2014, he served as Chief Financial Officer of Acino Holding. Prior to this he was Vice President Head of Finance EMEA at Synthes and held Chief Financial Officer and Chief Operating Officer positions at Delenex Therapeutics and ESBATech, two privately held biotech companies. From 2002 to the beginning of 2006, he was Chief Financial Officer of Straumann, which he had joined in 1997 as Head of Group Controlling and Reporting. Between 1986 and 1997, Martin was an Audit Engagement Manager at PricewaterhouseCoopers, Basel, Switzerland. Martin is a Swiss-certified fiduciary and Swiss-certified public accountant. He has also completed several executive-level development programs at IMD (the lnternational Institute for Management Development) in Lausanne, Switzerland. From 2012 to 2020 he served as a Board Member and Chairman of the Audit Committee of Evolva Holding. He is a Board Member of the University Center of Dentistry, Basel (UZB) and serves as Chairman of a privately-held diagnostic start-up company.
At Santhera, in addition to his role as Member of the Board, Martin Gertsch serves as Chairman of the Audit Committee.